Galectin Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GALT and other ETFs, options, and stocks.

About GALT

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. 

CEO
Joel Lewis
CEOJoel Lewis
Employees
15
Employees15
Headquarters
Norcross, Georgia
HeadquartersNorcross, Georgia
Founded
2000
Founded2000
Employees
15
Employees15

GALT Key Statistics

Market cap
181.19M
Market cap181.19M
Price-Earnings ratio
-4.74
Price-Earnings ratio-4.74
Dividend yield
Dividend yield
Average volume
279.28K
Average volume279.28K
High today
$2.89
High today$2.89
Low today
$2.67
Low today$2.67
Open price
$2.82
Open price$2.82
Volume
472.31K
Volume472.31K
52 Week high
$7.13
52 Week high$7.13
52 Week low
$1.12
52 Week low$1.12

Stock Snapshot

With a market cap of 181.19M, Galectin Therapeutics(GALT) trades at $2.80. The stock has a price-to-earnings ratio of -4.74.

On 2026-02-08, Galectin Therapeutics(GALT) stock traded between a low of $2.67 and a high of $2.89. Shares are currently priced at $2.80, which is +4.9% above the low and -3.1% below the high.

Galectin Therapeutics(GALT) shares are trading with a volume of 472.31K, against a daily average of 279.28K.

During the past year, Galectin Therapeutics(GALT) stock moved between $1.12 at its lowest and $7.13 at its peak.

During the past year, Galectin Therapeutics(GALT) stock moved between $1.12 at its lowest and $7.13 at its peak.

People also own

Based on the portfolios of people who own GALT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.